Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid LeukemiaBrandi Anders, Aaron Cumpston, Nilay Shah et al.|Advances in Hematology|2017Cited by 6
Outcomes of six-dose high-dose cytarabine (HiDAC-6) as a salvage regimen for patients with relapsed/refractory acute myeloid leukemia (RR-AML).Lauren Veltri, Aaron Cumpston, Brandi Anders et al.|Journal of Clinical Oncology|2016Cited by 0